RANK ligand inhibition with denosumab for the management of osteoporosis.
Lewiecki, E Michael
RANK ligand inhibition with denosumab for the management of osteoporosis. [electronic resource] - Expert opinion on biological therapy Oct 2006 - 1041-50 p. digital
Publication Type: Journal Article; Review
1744-7682
10.1517/14712598.6.10.1041 doi
Animals
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Denosumab
Disease Management
Humans
Osteoporosis--immunology
RANK Ligand--antagonists & inhibitors
RANK ligand inhibition with denosumab for the management of osteoporosis. [electronic resource] - Expert opinion on biological therapy Oct 2006 - 1041-50 p. digital
Publication Type: Journal Article; Review
1744-7682
10.1517/14712598.6.10.1041 doi
Animals
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Denosumab
Disease Management
Humans
Osteoporosis--immunology
RANK Ligand--antagonists & inhibitors